Taken together, our work establishes Adgrg6 as a novel regulator of IVD endplate and growth plate integrity in the mouse and suggests that modulation of ADGRG6/STAT3 signaling could provide robust disease-modifying targets for endplate-oriented disc degeneration, in humans. Here, STAT3 is linked to intervertebral disk degenerative disorder.